Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dexmedetomidine on somatosensory- and motor-evoked potentials under propofol anesthesia in spinal surgery
IRCT20160307026950N86Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in Back disorder, sponsored by Isfahan University of Medical Sciences. Primary endpoints: Change in somatosensory-evoked potential (SSEP) parameters and Change in motor-evoked potential (MEP) parameters. Started Aug 2026; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Back disorder
Beyond the preview
Go deeper on IRCT20160307026950N86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N86.